☰

Holly Janes, Ph.D. - Publications

Affiliations: 
2005 University of Washington, Seattle, Seattle, WA 
Area:
Statistics, Public Health
Tree Info Similar researchers PubMed Report error

49/206 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Marsh TL, Janes H, Pepe MS. Statistical inference for net benefit measures in biomarker validation studies. Biometrics. PMID 31732971 DOI: 10.1111/Biom.13190  0.598
2019 Li SS, Gilbert PB, Carpp LN, Pyo CW, Janes H, Fong Y, Shen X, Neidich SD, Goodman D, deCamp A, Cohen KW, Ferrari G, Hammer SM, Sobieszczyk ME, Mulligan MJ, et al. Fc gamma receptor polymorphisms modulated the vaccine effect on HIV-1 risk in the HVTN 505 HIV vaccine trial. Journal of Virology. PMID 31434737 DOI: 10.1128/Jvi.02041-18  0.3
2019 Kerr KF, Brown MD, Marsh TL, Janes H. Assessing the Clinical Impact of Risk Models for Opting Out of Treatment. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X18819479. PMID 30649998 DOI: 10.1177/0272989X18819479  0.393
2018 Kang C, Janes H, Tajik P, Groen H, Mol B, Koopmans C, Broekhuijsen K, Zwertbroek E, van Pampus M, Franssen M. Evaluation of biomarkers for treatment selection using individual participant data from multiple clinical trials. Statistics in Medicine. PMID 29444553 DOI: 10.1002/Sim.7608  0.397
2017 Kerr KF, Janes H. First things first: risk model performance metrics should reflect the clinical application. Statistics in Medicine. 36: 4503-4508. PMID 29156498 DOI: 10.1002/Sim.7341  0.434
2017 Dai JY, Liang CJ, LeBlanc M, Prentice RL, Janes H. Case-only approach to identifying markers predicting treatment effects on the relative risk scale. Biometrics. PMID 28960244 DOI: 10.1111/Biom.12789  0.405
2016 Kerr KF, Brown MD, Zhu K, Janes H. Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27247223 DOI: 10.1200/Jco.2015.65.5654  0.372
2016 Pepe MS, Janes H, Li CI, Bossuyt PM, Feng Z, Hilden J. Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility? Clinical Chemistry. PMID 27001493 DOI: 10.1373/Clinchem.2015.252163  0.517
2016 Urban N, Hawley S, Janes H, Karlan BY, Drescher CW, Daly MB, Anderson GL. Abstract IA20: Biomarkers for risk prediction, screening, and early diagnostics. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-Ia20  0.4
2015 Urban N, Hawley S, Janes H, Karlan BY, Berg CD, Drescher CW, Manson JE, Palomares MR, Daly MB, Wactawski-Wende J, O'Sullivan MJ, Thorpe J, Robinson RD, Lane D, Li CI, et al. Identifying post-menopausal women at elevated risk for epithelial ovarian cancer. Gynecologic Oncology. PMID 26343159 DOI: 10.1016/J.Ygyno.2015.08.024  0.347
2015 Huang Y, Follmann D, Nason M, Zhang L, Huang Y, Mehrotra DV, Moodie Z, Metch B, Janes H, Keefer MC, Churchyard G, Robb ML, Fast PE, Duerr A, McElrath MJ, et al. Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials. Plos One. 10: e0136626. PMID 26332672 DOI: 10.1371/Journal.Pone.0136626  0.318
2015 Janes H, Brown MD, Pepe MS. Designing a study to evaluate the benefit of a biomarker for selecting patient treatment. Statistics in Medicine. PMID 26112650 DOI: 10.1002/Sim.6564  0.562
2015 Janes H, Pepe MS, McShane LM, Sargent DJ, Heagerty PJ. The Fundamental Difficulty With Evaluating the Accuracy of Biomarkers for Guiding Treatment. Journal of the National Cancer Institute. 107. PMID 26109106 DOI: 10.1093/Jnci/Djv157  0.541
2015 Huang Y, Laber EB, Janes H. Characterizing expected benefits of biomarkers in treatment selection. Biostatistics (Oxford, England). 16: 383-99. PMID 25190512 DOI: 10.1093/Biostatistics/Kxu039  0.383
2014 Li SS, Gilbert PB, Tomaras GD, Kijak G, Ferrari G, Thomas R, Pyo CW, Zolla-Pazner S, Montefiori D, Liao HX, Nabel G, Pinter A, Evans DT, Gottardo R, Dai JY, ... Janes H, et al. FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial. The Journal of Clinical Investigation. 124: 3879-90. PMID 25105367 DOI: 10.1172/Jci75539  0.301
2014 Kang C, Janes H, Huang Y. Rejoinder: Combining biomarkers to optimize patient treatment recommendations. Biometrics. 70: 719-20. PMID 24889787 DOI: 10.1111/Biom.12192  0.382
2014 Kang C, Janes H, Huang Y. Combining biomarkers to optimize patient treatment recommendations. Biometrics. 70: 695-707. PMID 24889663 DOI: 10.1111/Biom.12191  0.381
2014 Janes H, Brown MD, Huang Y, Pepe MS. An approach to evaluating and comparing biomarkers for patient treatment selection. The International Journal of Biostatistics. 10: 99-121. PMID 24695044 DOI: 10.1515/Ijb-2012-0052  0.587
2014 Pepe MS, Janes H, Li CI. Net risk reclassification p values: valid or misleading? Journal of the National Cancer Institute. 106: dju041. PMID 24681599 DOI: 10.1093/Jnci/Dju041  0.606
2014 Kerr KF, Wang Z, Janes H, McClelland RL, Psaty BM, Pepe MS. Net reclassification indices for evaluating risk prediction instruments: a critical review. Epidemiology (Cambridge, Mass.). 25: 114-21. PMID 24240655 DOI: 10.1097/Ede.0000000000000018  0.603
2014 Janes H, Pepe MS, Huang Y. A framework for evaluating markers used to select patient treatment. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 34: 159-67. PMID 23811760 DOI: 10.1177/0272989X13493147  0.617
2013 Janes H, Gilbert P, Buchbinder S, Kublin J, Sobieszczyk ME, Hammer SM. In pursuit of an HIV vaccine: designing efficacy trials in the context of partially effective nonvaccine prevention modalities. Aids Research and Human Retroviruses. 29: 1513-23. PMID 23597282 DOI: 10.1089/Aid.2012.0385  0.301
2013 Janes H, Pepe M. Re: "Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study". American Journal of Epidemiology. 177: 864-5. PMID 23524037 DOI: 10.1093/Aje/Kwt043  0.556
2013 Pepe M, Janes H. Methods for evaluating prediction performance of biomarkers and tests Lecture Notes in Statistics. 215: 107-142. DOI: 10.1007/978-1-4614-8981-8_7  0.571
2012 Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam SM, Evans DT, Montefiori DC, Karnasuta C, Sutthent R, Liao HX, DeVico AL, Lewis GK, Williams C, Pinter A, ... ... Janes H, et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. The New England Journal of Medicine. 366: 1275-86. PMID 22475592 DOI: 10.1056/Nejmoa1113425  0.314
2012 Huang Y, Gilbert PB, Janes H. Assessing treatment-selection markers using a potential outcomes framework. Biometrics. 68: 687-96. PMID 22299708 DOI: 10.1111/j.1541-0420.2011.01722.x  0.317
2011 Pepe MS, Janes H. Commentary: Reporting standards are needed for evaluations of risk reclassification. International Journal of Epidemiology. 40: 1106-8. PMID 21571811 DOI: 10.1093/Ije/Dyr083  0.616
2011 Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, et al. Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. European Journal of Clinical Investigation. 41: 1010-35. PMID 21434890 DOI: 10.1111/J.1365-2362.2011.02493.X  0.382
2011 Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, et al. Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. European Journal of Epidemiology. 26: 313-37. PMID 21424820 DOI: 10.1007/S10654-011-9551-Z  0.381
2011 Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, et al. Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. Journal of Clinical Epidemiology. 64: e1-e22. PMID 21414753 DOI: 10.1016/J.Jclinepi.2011.02.003  0.381
2011 Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, et al. Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. European Journal of Human Genetics : Ejhg. 19: 18 p preceding 494. PMID 21407270 DOI: 10.1038/Ejhg.2011.27  0.381
2011 Janes H, Pepe MS, Bossuyt PM, Barlow WE. Measuring the performance of markers for guiding treatment decisions. Annals of Internal Medicine. 154: 253-9. PMID 21320940 DOI: 10.7326/0003-4819-154-4-201102150-00006  0.581
2010 Janes H, Dominici F, Zeger S. On quantifying the magnitude of confounding. Biostatistics (Oxford, England). 11: 572-82. PMID 20203259 DOI: 10.1093/Biostatistics/Kxq007  0.305
2009 Janes H, Pepe MS. Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve. Biometrika. 96: 371-382. PMID 22822245 DOI: 10.1093/Biomet/Asp002  0.576
2009 Pepe M, Longton G, Janes H. Estimation and Comparison of Receiver Operating Characteristic Curves. The Stata Journal. 9: 1. PMID 20161343 DOI: 10.1177/1536867X0900900101  0.577
2009 Janes H, Longton G, Pepe M. Accommodating Covariates in ROC Analysis. The Stata Journal. 9: 17-39. PMID 20046933  0.553
2009 Janes H, Longton G, Pepe MS. Accommodating covariates in receiver operating characteristic analysis Stata Journal. 9: 17-39. DOI: 10.1177/1536867X0900900102  0.591
2009 Janes H, Pepe MS, Gu W. In response Annals of Internal Medicine. 150: 428.  0.408
2008 Janes H, Pepe MS, Gu W. Assessing the value of risk predictions by using risk stratification tables. Annals of Internal Medicine. 149: 751-60. PMID 19017593 DOI: 10.7326/0003-4819-149-10-200811180-00009  0.674
2008 Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. Journal of the National Cancer Institute. 100: 1432-8. PMID 18840817 DOI: 10.1093/Jnci/Djn326  0.595
2008 Pepe MS, Janes HE. Gauging the performance of SNPs, biomarkers, and clinical factors for predicting risk of breast cancer. Journal of the National Cancer Institute. 100: 978-9. PMID 18612128 DOI: 10.1093/Jnci/Djn215  0.574
2008 Janes H, Pepe MS. Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting. American Journal of Epidemiology. 168: 89-97. PMID 18477651 DOI: 10.1093/Aje/Kwn099  0.577
2008 Janes H, Pepe MS. Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value. Biometrics. 64: 1-9. PMID 17501939 DOI: 10.1111/J.1541-0420.2007.00823.X  0.592
2007 Pepe MS, Janes H, Gu JW. Letter by Pepe et al regarding article, "Use and misuse of the receiver operating characteristic curve in risk prediction". Circulation. 116: e132; author reply e. PMID 17679623 DOI: 10.1161/Circulationaha.107.709253  0.611
2007 Pepe MS, Janes H. Insights into latent class analysis of diagnostic test performance. Biostatistics (Oxford, England). 8: 474-84. PMID 17085745 DOI: 10.1093/Biostatistics/Kxl038  0.552
2006 Lumley T, Janes H, Sheppard L. Cox models for ecologic time-series data? Environmental Health Perspectives. 114: A690-1; author reply. PMID 17185253 DOI: 10.1289/Ehp.114-1764157  0.351
2006 Janes H, Pepe M. The optimal ratio of cases to controls for estimating the classification accuracy of a biomarker. Biostatistics (Oxford, England). 7: 456-68. PMID 16428259 DOI: 10.1093/Biostatistics/Kxj018  0.568
2005 Janes H, Pepe M, Kooperberg C, Newcomb P. Identifying target populations for screening or not screening using logic regression. Statistics in Medicine. 24: 1321-38. PMID 15568185 DOI: 10.1002/Sim.2021  0.56
2004 Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. American Journal of Epidemiology. 159: 882-90. PMID 15105181 DOI: 10.1093/Aje/Kwh101  0.556
Low-probability matches (unlikely to be authored by this person)
2019 Westling T, Juraska M, Seaton KE, Tomaras GD, Gilbert PB, Janes H. Methods for comparing durability of immune responses between vaccine regimens in early-phase trials. Statistical Methods in Medical Research. 962280218820881. PMID 30623732 DOI: 10.1177/0962280218820881  0.298
2017 Janes H, Brown MD, Crager MR, Miller DP, Barlow WE. Adjusting for covariates in evaluating markers for selecting treatment, with application to guiding chemotherapy for treating estrogen-receptor-positive, node-positive breast cancer. Contemporary Clinical Trials. PMID 28818434 DOI: 10.1016/j.cct.2017.08.004  0.297
2016 Huang Y, DiazGranados C, Janes H, Huang Y, deCamp AC, Metch B, Grant S, Sanchez B, Phogat S, Koutsoukos M, Kanesa-Thasan N, Bourguignon P, Collard A, Buchbinder S, Tomaras GD, et al. Selection of HIV vaccine candidates for concurrent testing in an efficacy trial. Current Opinion in Virology. 17: 57-65. PMID 26827165 DOI: 10.1016/J.Coviro.2016.01.007  0.295
2014 Gartland AJ, Li S, McNevin J, Tomaras GD, Gottardo R, Janes H, Fong Y, Morris D, Geraghty DE, Kijak GH, Edlefsen PT, Frahm N, Larsen BB, Tovanabutra S, Sanders-Buell E, et al. Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial. Journal of Virology. 88: 8242-55. PMID 24829343 DOI: 10.1128/Jvi.01164-14  0.289
2019 Janes H, Donnell D, Gilbert PB, Brown ER, Nason M. Taking stock of the present and looking ahead: envisioning challenges in the design of future HIV prevention efficacy trials. The Lancet. Hiv. PMID 31078451 DOI: 10.1016/S2352-3018(19)30133-X  0.288
2008 McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R, Buchbinder SP, Robertson MN, Mehrotra DV, Self SG, Corey L, et al. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet (London, England). 372: 1894-905. PMID 19012957 DOI: 10.1016/S0140-6736(08)61592-5  0.285
2019 Janes H, Brown MD, Glidden DV, Mayer KH, Buchbinder SP, McMahan VM, Schechter M, Guanira J, Casapia M. Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors. Plos One. 14: e0222183. PMID 31536518 DOI: 10.1371/Journal.Pone.0222183  0.283
2011 Fitzgerald DW, Janes H, Robertson M, Coombs R, Frank I, Gilbert P, Loufty M, Mehrotra D, Duerr A. An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: Results from a randomized placebo-controlled trial (The step study) Journal of Infectious Diseases. 203: 765-772. PMID 21343146 DOI: 10.1093/Infdis/Jiq114  0.28
2010 Seaman MS, Janes H, Hawkins N, Grandpre LE, Devoy C, Giri A, Coffey RT, Harris L, Wood B, Daniels MG, Bhattacharya T, Lapedes A, Polonis VR, McCutchan FE, Gilbert PB, et al. Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. Journal of Virology. 84: 1439-52. PMID 19939925 DOI: 10.1128/Jvi.02108-09  0.279
2019 Pantaleo G, Janes H, Karuna S, Grant S, Ouedraogo GL, Allen M, Tomaras GD, Frahm N, Montefiori DC, Ferrari G, Ding S, Lee C, Robb ML, Esteban M, Wagner R, et al. Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial. The Lancet. Hiv. PMID 31601541 DOI: 10.1016/S2352-3018(19)30262-0  0.278
2008 Janes H, Sheppard L, Shepherd K. Statistical analysis of air pollution panel studies: an illustration. Annals of Epidemiology. 18: 792-802. PMID 18922395 DOI: 10.1016/J.Annepidem.2008.06.004  0.278
2013 Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD, Frahm N, Hural J, Anude C, Graham BS, Enama ME, et al. Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. The New England Journal of Medicine. 369: 2083-92. PMID 24099601 DOI: 10.1056/Nejmoa1310566  0.274
2013 Janes H, Friedrich DP, Krambrink A, Smith RJ, Kallas EG, Horton H, Casimiro DR, Carrington M, Geraghty DE, Gilbert PB, McElrath MJ, Frahm N. Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection. The Journal of Infectious Diseases. 208: 1231-9. PMID 23878319 DOI: 10.1093/Infdis/Jit322  0.272
2020 Palli R, Seaton KE, Piepenbrink MS, Hural J, Goepfert PA, Laher F, Buchbinder SP, Churchyard G, Gray GE, Robinson HL, Huang Y, Janes H, Kobie JJ, Keefer MC, Tomaras GD, et al. Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature. Scientific Reports. 10: 13031. PMID 32747654 DOI: 10.1038/S41598-020-69007-W  0.264
2016 Gilbert PB, Janes HE, Huang Y. Power/sample size calculations for assessing correlates of risk in clinical efficacy trials. Statistics in Medicine. PMID 27037797 DOI: 10.1002/sim.6952  0.26
2007 Janes H, Dominici F, Zeger SL. Trends in air pollution and mortality: an approach to the assessment of unmeasured confounding. Epidemiology (Cambridge, Mass.). 18: 416-23. PMID 17568215 DOI: 10.1097/Ede.0B013E31806462E9  0.248
2017 Kerr KF, LeBlanc M, Janes H. Comparisons of cancer staging systems should be based on overall performance in the population. Clinical Trials (London, England). 1740774517722141. PMID 28819997 DOI: 10.1177/1740774517722141  0.245
2015 Janes H, Herbeck JT, Tovanabutra S, Thomas R, Frahm N, Duerr A, Hural J, Corey L, Self SG, Buchbinder SP, McElrath MJ, O'Connell RJ, Paris RM, Rerks-Ngarm S, Nitayaphan S, et al. HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders. Nature Medicine. PMID 26322580 DOI: 10.1038/Nm.3932  0.244
2019 Kerr KF, Marsh TL, Janes H. The Importance of Uncertainty and Opt-In v. Opt-Out: Best Practices for Decision Curve Analysis. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X19849436. PMID 31104561 DOI: 10.1177/0272989X19849436  0.242
2008 Eftim SE, Samet JM, Janes H, McDermott A, Dominici F. Fine particulate matter and mortality: a comparison of the six cities and American Cancer Society cohorts with a medicare cohort. Epidemiology (Cambridge, Mass.). 19: 209-16. PMID 18223484 DOI: 10.1097/Ede.0B013E3181632C09  0.241
2017 Janes H. STEPHEN W. LOONEY and JOSEPH L. HAGAN. Analysis of Biomarker Data: A Practical Guide. Hoboken: Wiley. Biometrics. 73: 1468-1468. DOI: 10.1111/Biom.12828  0.236
2012 Hertz T, Gartland A, Janes H, Li S, Fong Y, Tomaras G, Morris D, Geraghty D, Kijak G, Edlefsen P, Rolland M, Larsen B, Tovanabutra S, Sanders-Buell E, DeCamp A, et al. T-cell based sieve analysis ties HLA A*02 to vaccine efficacy and IgA-C1 immune correlate in RV144 Thai trial Retrovirology. 9. DOI: 10.1186/1742-4690-9-S2-O61  0.225
2020 Hejazi NS, van der Laan MJ, Janes HE, Gilbert PB, Benkeser DC. Efficient nonparametric inference on the effects of stochastic interventions under two-phase sampling, with applications to vaccine efficacy trials. Biometrics. PMID 32949147 DOI: 10.1111/biom.13375  0.215
2007 Janes H, Dominici F, Zeger S. Partitioning evidence of association between air pollution and mortality Epidemiology. 18: 427-428. DOI: 10.1097/Ede.0B013E318068647B  0.197
2023 Theodore DA, Branche AR, Zhang L, Graciaa DS, Choudhary M, Hatlen TJ, Osman R, Babu TM, Robinson ST, Gilbert PB, Follmann D, Janes H, Kublin JG, Baden LR, Goepfert P, et al. Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials. Jama Network Open. 6: e2323349. PMID 37440227 DOI: 10.1001/jamanetworkopen.2023.23349  0.193
2017 Janes HE, Cohen KW, Frahm N, De Rosa SC, Sanchez B, Hural J, Magaret CA, Karuna S, Bentley C, Gottardo R, Finak G, Grove D, Shen M, Graham BS, Koup RA, et al. Higher T cell responses induced by DNA/rAd5 HIV-1 preventive vaccine are associated with lower HIV-1 infection risk in an efficacy trial. The Journal of Infectious Diseases. PMID 28199679 DOI: 10.1093/Infdis/Jix086  0.189
2016 Hanscom B, Janes HE, Guarino PD, Huang Y, Brown ER, Chen YQ, Hammer SM, Gilbert PB, Donnell DJ. Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current Evidence. Journal of Acquired Immune Deficiency Syndromes (1999). 73: 606-608. PMID 27846073 DOI: 10.1097/QAI.0000000000001160  0.186
2005 Janes H, Sheppard L, Lumley T. Overlap bias in the case-crossover design, with application to air pollution exposures. Statistics in Medicine. 24: 285-300. PMID 15546133 DOI: 10.1002/Sim.1889  0.182
2020 Janes H, Zhu Y, Brown ER. Designing HIV Vaccine Efficacy Trials in the Context of Highly Effective Non-vaccine Prevention Modalities. Statistics in Biosciences. 12: 468-494. PMID 36938334 DOI: 10.1007/s12561-020-09292-1  0.181
2005 Janes H, Sheppard L, Lumley T. Case-crossover analyses of air pollution exposure data: referent selection strategies and their implications for bias. Epidemiology (Cambridge, Mass.). 16: 717-26. PMID 16222160 DOI: 10.1097/01.Ede.0000181315.18836.9D  0.179
2016 Huang Y, Gilbert PB, Fu R, Janes H. Statistical methods for down-selection of treatment regimens based on multiple endpoints, with application to HIV vaccine trials. Biostatistics (Oxford, England). PMID 27649715 DOI: 10.1093/biostatistics/kxw043  0.178
2015 Huang Y, Karuna ST, Janes H, Frahm N, Nason M, Edlefsen PT, Kublin JG, Corey L, McElrath MJ, Gilbert PB. Use of placebos in Phase 1 preventive HIV vaccine clinical trials. Vaccine. 33: 749-52. PMID 25454855 DOI: 10.1016/J.Vaccine.2014.10.017  0.177
2021 Lin DY, Gu Y, Zeng D, Janes HE, Gilbert PB. Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34260716 DOI: 10.1093/cid/ciab630  0.177
2021 Lin DY, Gu Y, Zeng D, Janes HE, Gilbert PB. Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34260716 DOI: 10.1093/cid/ciab630  0.177
2021 Lin DY, Gu Y, Zeng D, Janes HE, Gilbert PB. Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection. Medrxiv : the Preprint Server For Health Sciences. PMID 33880481 DOI: 10.1101/2021.04.16.21255614  0.177
2023 Bannick MS, Gao F, Brown ER, Janes HE. Retrospective, Observational Studies for Estimating Vaccine Effects on the Secondary Attack Rate of SARS-CoV-2. American Journal of Epidemiology. PMID 36883907 DOI: 10.1093/aje/kwad046  0.176
2016 Hanscom B, Janes HE, Guarino PD, Huang Y, Brown ER, Chen YQ, Hammer SM, Gilbert PB, Donnell DJ. Preventing HIV-1 Infection in Women using Oral Pre-Exposure Prophylaxis: A Meta-analysis of Current Evidence. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27552075 DOI: 10.1097/QAI.0000000000001160  0.169
2023 Prudden HJ, Tatoud R, Janes H, Wallace S, Miller V, Bekker LG, Donnell D. Perspectives on Design Approaches for HIV Prevention Efficacy Trials. Aids Research and Human Retroviruses. PMID 37392020 DOI: 10.1089/AID.2022.0150  0.166
2018 Janes H, Corey L, Ramjee G, Carpp LN, Lombard C, Cohen MS, Gilbert PB, Gray GE. Weighing the evidence of efficacy of oral PrEP for HIV prevention in women in southern Africa. Aids Research and Human Retroviruses. PMID 29732896 DOI: 10.1089/Aid.2018.0031  0.165
2018 Fong Y, Shen X, Ashley VC, Deal A, Seaton KE, Yu C, Grant SP, Ferrari G, deCamp AC, Bailer RT, Koup RA, Montefiori D, Haynes BF, Sarzotti-Kelsoe M, Graham BS, ... ... Janes HE, et al. Vaccine-induced antibody responses modify the association between T-cell immune responses and HIV-1 infection risk in HVTN 505. The Journal of Infectious Diseases. PMID 29325070 DOI: 10.1093/Infdis/Jiy008  0.164
2023 Benkeser D, Fong Y, Janes HE, Kelly EJ, Hirsch I, Sproule S, Stanley AM, Maaske J, Villafana T, Houchens CR, Martins K, Jayashankar L, Castellino F, Ayala V, Petropoulos CJ, et al. Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine. Npj Vaccines. 8: 36. PMID 36899062 DOI: 10.1038/s41541-023-00630-0  0.164
2022 Moodie Z, Dintwe O, Sawant S, Grove D, Huang Y, Janes H, Heptinstall J, Laher Omar F, Cohen K, De Rosa SC, Zhang L, Yates NL, Sarzotti-Kelsoe M, Seaton KE, Laher F, et al. Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk. The Journal of Infectious Diseases. PMID 35758878 DOI: 10.1093/infdis/jiac260  0.163
2019 Neidich SD, Fong Y, Li SS, Geraghty DE, Williamson BD, Young WC, Goodman D, Seaton KE, Shen X, Sawant S, Zhang L, deCamp AC, Blette BS, Shao M, Yates NL, ... ... Janes HE, et al. Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk. The Journal of Clinical Investigation. PMID 31589165 DOI: 10.1172/Jci126391  0.163
2020 Mehrotra DV, Janes HE, Fleming TR, Annunziato PW, Neuzil KM, Carpp LN, Benkeser D, Brown ER, Carone M, Cho I, Donnell D, Fay MP, Fong Y, Han S, Hirsch I, et al. Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials. Annals of Internal Medicine. PMID 33090877 DOI: 10.7326/M20-6169  0.16
2023 Malahleha M, Laher F, Dilraj A, Smith P, Gray GE, Grove D, Odhiambo JA, Andrasik MP, Grunenberg NA, Moodie Z, Huang Y, Borate BR, Gillespie KM, Allen M, Atujuna M, ... ... Janes H, et al. Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa. Aids and Behavior. PMID 36929319 DOI: 10.1007/s10461-023-04025-z  0.159
2021 Matrajt L, Brown ER, Dimitrov D, Janes H. The role of antiviral treatment in curbing the COVID-19 pandemic: a modeling study. Medrxiv : the Preprint Server For Health Sciences. PMID 34790985 DOI: 10.1101/2021.11.10.21266139  0.154
2019 Janes H, Donnell D, Nason M. Designing the Next Generation of HIV Prevention Efficacy Trials: Synopsis of a 2018 Symposium Statistical Communications in Infectious Diseases. 11. DOI: 10.1515/scid-2019-0004  0.149
2024 Donnell D, Kansiime S, Glidden DV, Luedtke A, Gilbert PB, Gao F, Janes H. Study design approaches for future active-controlled HIV prevention trials. Statistical Communications in Infectious Diseases. 15: 20230002. PMID 38250627 DOI: 10.1515/scid-2023-0002  0.149
2023 Benkeser D, Montefiori DC, McDermott AB, Fong Y, Janes HE, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Castellino F, Flach B, Lin BC, O'Connell S, McDanal C, et al. Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial. Science Translational Medicine. 15: eade9078. PMID 37075127 DOI: 10.1126/scitranslmed.ade9078  0.149
2017 Huang Y, Zhang L, Janes H, Frahm N, Isaacs A, Kim JH, Montefiori D, McElrath MJ, Tomaras GD, Gilbert PB. Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials. Vaccine. PMID 28131393 DOI: 10.1016/j.vaccine.2016.09.053  0.148
2022 Sobieszczyk ME, Maaske J, Falsey AR, Sproule S, Robb ML, Frenck RW, Tieu HV, Mayer KH, Corey L, Neuzil KM, Tong T, Brewinski Isaacs M, Janes H, Bansal H, Edwards LM, et al. Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months. The Journal of Clinical Investigation. 132. PMID 36106642 DOI: 10.1172/JCI160565  0.147
2022 Matrajt L, Brown ER, Cohen MS, Dimitrov D, Janes H. Could widespread use of antiviral treatment curb the COVID-19 pandemic? A modeling study. Bmc Infectious Diseases. 22: 683. PMID 35945513 DOI: 10.1186/s12879-022-07639-1  0.144
1991 Janes HW, Langley RB, Newby SP. Analysis of tropospheric delay prediction models: comparisons with ray-tracing and implications for GPS relative positioning Bulletin GéOdéSique. 65: 151-161. DOI: 10.1007/Bf00806344  0.144
2013 Moodie Z, Janes H, Huang Y. New clinical trial designs for HIV vaccine evaluation. Current Opinion in Hiv and Aids. 8: 437-42. PMID 23872613 DOI: 10.1097/COH.0b013e328363d46a  0.14
2023 Zhu Y, Gao F, Glidden DV, Donnell D, Janes H. Estimating counterfactual placebo HIV incidence in HIV prevention trials without placebo arms based on markers of HIV exposure. Clinical Trials (London, England). 17407745231203327. PMID 37877356 DOI: 10.1177/17407745231203327  0.139
2023 Rick AM, Laurens MB, Huang Y, Yu C, Martin TCS, Rodriguez CA, Rostad CA, Maboa RM, Baden LR, El Sahly HM, Grinsztejn B, Gray GE, Gay CL, Gilbert PB, Janes HE, et al. Risk of COVID-19 after natural infection or vaccination. Ebiomedicine. 96: 104799. PMID 37738833 DOI: 10.1016/j.ebiom.2023.104799  0.139
2023 Hejazi NS, Shen X, Carpp LN, Benkeser D, Follmann D, Janes HE, Baden LR, El Sahly HM, Deng W, Zhou H, Leav B, Montefiori DC, Gilbert PB. Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. 137: 28-39. PMID 37820782 DOI: 10.1016/j.ijid.2023.09.012  0.138
2023 Janes H, Buchbinder S. Control groups for HIV prevention efficacy trials: what does the future hold? Current Opinion in Hiv and Aids. 18: 349-356. PMID 37712852 DOI: 10.1097/COH.0000000000000818  0.137
2022 Bender Ignacio RA, Long J, Saha A, Nguyen FK, Joudeh L, Valinetz E, Mendelsohn SC, Scriba TJ, Hatherill M, Janes H, Churchyard G, Buchbinder S, Duerr A, Shah JA, Hawn TR. Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition. Plos One. 17: e0267729. PMID 35503767 DOI: 10.1371/journal.pone.0267729  0.136
2016 Gilbert PB, Huang Y, Janes HE. Modeling HIV vaccine trials of the future. Current Opinion in Hiv and Aids. PMID 27662407 DOI: 10.1097/COH.0000000000000314  0.136
2023 Huang Y, Hejazi NS, Blette B, Carpp LN, Benkeser D, Montefiori DC, McDermott AB, Fong Y, Janes HE, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Flach B, et al. Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial. Viruses. 15. PMID 37896806 DOI: 10.3390/v15102029  0.135
2022 Follmann D, Janes HE, Buhule OD, Zhou H, Girard B, Marks K, Kotloff K, Desjardins M, Corey L, Neuzil KM, Miller JM, El Sahly HM, Baden LR. Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial. Annals of Internal Medicine. PMID 35785530 DOI: 10.7326/M22-1300  0.134
2023 Mena Lora AJ, Long JE, Huang Y, Baden LR, El Sahly HM, Follmann D, Goepfert P, Gray G, Grinsztejn B, Kotloff K, Rouphael N, Sobieszczyk M, Walsh SR, Andriesen J, Shah KA, ... ... Janes H, et al. Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials. Jama Network Open. 6: e2251974. PMID 36689221 DOI: 10.1001/jamanetworkopen.2022.51974  0.133
2020 Zhao LP, Fiore-Gartland A, Carpp LN, Cohen KW, Rouphael N, Fleurs L, Dintwe O, Zhao M, Moodie Z, Fong Y, Garrett N, Huang Y, Innes C, Janes HE, Lazarus E, et al. Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans. Plos One. 15: e0226803. PMID 31999736 DOI: 10.1371/Journal.Pone.0226803  0.133
2012 Janes H, Frahm N, DeCamp A, Rolland M, Gabriel E, Wolfson J, Hertz T, Kallas E, Goepfert P, Friedrich DP, Corey L, Mullins JI, McElrath MJ, Gilbert P. MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral load. Plos One. 7: e43396. PMID 22952672 DOI: 10.1371/Journal.Pone.0043396  0.127
2020 Follmann D, Fintzi J, Fay MP, Janes HE, Baden L, Sahly HE, Fleming TR, Mehrotra DV, Carpp LN, Juraska M, Benkeser D, Donnell D, Fong Y, Han S, Hirsch I, et al. Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials. Medrxiv : the Preprint Server For Health Sciences. PMID 33336213 DOI: 10.1101/2020.12.14.20248137  0.125
2021 Swan DA, Goyal A, Bracis C, Moore M, Krantz E, Brown E, Cardozo-Ojeda F, Reeves DB, Gao F, Gilbert PB, Corey L, Cohen MS, Janes H, Dimitrov D, Schiffer JT. Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission. Viruses. 13. PMID 34696352 DOI: 10.3390/v13101921  0.124
2021 El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, ... ... Janes H, et al. Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. The New England Journal of Medicine. PMID 34551225 DOI: 10.1056/NEJMoa2113017  0.124
2021 Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, Robb ML, Corey L, Neuzil KM, Hahn W, Hunt J, Mulligan MJ, McEvoy C, DeJesus E, Hassman M, Little SJ, Pahud BA, ... ... Janes HE, et al. Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine. The New England Journal of Medicine. PMID 34587382 DOI: 10.1056/NEJMoa2105290  0.123
2021 Janes H, Gao F, Luedtke A. Discussion on "Estimating vaccine efficacy over time after a randomized study is unblinded" by Anastasios A. Tsiatis and Marie Davidian. Biometrics. PMID 34492117 DOI: 10.1111/biom.13542  0.122
2023 Follmann D, O'Brien MP, Fintzi J, Fay MP, Montefiori D, Mateja A, Herman GA, Hooper AT, Turner KC, Chan KC, Forleo-Neto E, Isa F, Baden LR, El Sahly HM, Janes H, et al. Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration. Nature Communications. 14: 3605. PMID 37330602 DOI: 10.1038/s41467-023-39292-w  0.121
2024 Moore M, Zhu Y, Hirsch I, White T, Reiner RC, Barber RM, Pigott D, Collins JK, Santoni S, Sobieszczyk ME, Janes H. Estimating vaccine efficacy during open-label follow-up of COVID-19 vaccine trials based on population-level surveillance data. Epidemics. 47: 100768. PMID 38643547 DOI: 10.1016/j.epidem.2024.100768  0.12
2024 Sherman A, Tuan J, Cantos VD, Adeyiga O, Mahoney S, Ortega-Villa AM, Tillman A, Whitaker J, Woodward Davis AS, Leav B, Hirsch I, Sadoff J, Dunkle LM, Gilbert PB, Janes HE, et al. COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 38598658 DOI: 10.1093/cid/ciae192  0.12
2021 Lewitus E, Sanders-Buell E, Bose M, O'Sullivan AM, Poltavee K, Li Y, Bai H, Mdluli T, Donofrio G, Slike B, Zhao H, Wong K, Chen L, Miller S, Lee J, ... ... Janes H, et al. RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection. Virus Evolution. 7: veab057. PMID 34532060 DOI: 10.1093/ve/veab057  0.12
2021 Gray GE, Bekker LG, Laher F, Malahleha M, Allen M, Moodie Z, Grunenberg N, Huang Y, Grove D, Prigmore B, Kee JJ, Benkeser D, Hural J, Innes C, Lazarus E, ... ... Janes H, et al. Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults. The New England Journal of Medicine. 384: 1089-1100. PMID 33761206 DOI: 10.1056/NEJMoa2031499  0.119
2021 Follmann D, Fintzi J, Fay MP, Janes HE, Baden LR, El Sahly HM, Fleming TR, Mehrotra DV, Carpp LN, Juraska M, Benkeser D, Donnell D, Fong Y, Han S, Hirsch I, et al. A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated. Annals of Internal Medicine. PMID 33844575 DOI: 10.7326/M20-8149  0.118
2004 Moraru C, Logendra L, Lee TC, Janes H. Characteristics of 10 processing tomato cultivars grown hydroponically for the NASA Advanced Life Support (ALS) Program Journal of Food Composition and Analysis. 17: 141-154. DOI: 10.1016/J.Jfca.2003.08.003  0.115
2022 Marcelin JR, Pettifor A, Janes H, Brown ER, Kublin JG, Stephenson KE. COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective. Open Forum Infectious Diseases. 9: ofac124. PMID 35493113 DOI: 10.1093/ofid/ofac124  0.114
2023 Follmann D, Janes HE, Chu E, Jayashankar L, Petropoulos CJ, Serebryannyy L, Carroll R, Jean-Baptiste N, Narpala S, Lin BC, McDermott A, Novak RM, Graciaa DS, Rolsma S, Magaret CA, et al. Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial. Open Forum Infectious Diseases. 10: ofad069. PMID 36895286 DOI: 10.1093/ofid/ofad069  0.107
2020 Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Kehtan S, Segall N, Solis J, Brosz A, ... ... Janes H, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. The New England Journal of Medicine. PMID 33378609 DOI: 10.1056/NEJMoa2035389  0.106
2020 Martin AR, Patel EU, Kirby C, Astemborski J, Kirk GD, Mehta SH, Marshall K, Janes H, Clayton A, Corey L, Hammer SM, Sobieszczyk ME, Arthos J, Cicala C, Redd AD, et al. The association of α4β7 expression with HIV acquisition and disease progression in people who inject drugs and men who have sex with men: Case control studies. Ebiomedicine. 62: 103102. PMID 33166790 DOI: 10.1016/j.ebiom.2020.103102  0.106
2021 Swan DA, Bracis C, Janes H, Moore M, Matrajt L, Reeves DB, Burns E, Donnell D, Cohen MS, Schiffer JT, Dimitrov D. COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact. Scientific Reports. 11: 15531. PMID 34330945 DOI: 10.1038/s41598-021-94719-y  0.105
2011 Barnabas RV, Wasserheit JN, Huang Y, Janes H, Morrow R, Fuchs J, Mark KE, Casapia M, Mehrotra DV, Buchbinder SP, Corey L. Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study). Journal of Acquired Immune Deficiency Syndromes (1999). 57: 238-44. PMID 21860356 DOI: 10.1097/Qai.0B013E31821Acb5  0.103
2023 Mashingaidze R, Moodie Z, Allen M, Bekker LG, Grove D, Grunenberg N, Huang Y, Janes HE, Lazarus EM, Malahleha M, Nchabeleng M, Laher F. Sexually transmitted infections amongst men who have sex with men (MSM) in South Africa. Plos Global Public Health. 3: e0001782. PMID 37018240 DOI: 10.1371/journal.pgph.0001782  0.102
2021 Matrajt L, Janes H, Schiffer JT, Dimitrov D. Quantifying the Impact of Lifting Community Nonpharmaceutical Interventions for COVID-19 During Vaccination Rollout in the United States. Open Forum Infectious Diseases. 8: ofab341. PMID 34307733 DOI: 10.1093/ofid/ofab341  0.099
1999 Logendra LS, Janes HW. Hydroponic tomato production: Growing media requirements Acta Horticulturae. 481: 483-486.  0.099
1955 Taddeo MC, Janes HH. Intussusception due to invaginated Meckel's diverticulum after previous appendectomy The American Journal of Surgery. 89: 696-699. PMID 13228832  0.098
2017 Murphy SC, Duke ER, Shipman KJ, Jensen RL, Fong Y, Ferguson S, Janes HE, Gillespie K, Seilie AM, Hanron AE, Rinn L, Fishbaugher M, VonGoedert T, Fritzen E, Kappe SH, et al. A randomized trial of the prophylactic activity of DSM265 against pre-erythrocytic Plasmodium falciparum controlled human malaria infection by mosquito bites and direct venous inoculation. The Journal of Infectious Diseases. PMID 29216395 DOI: 10.1093/Infdis/Jix613  0.092
2006 Janes H. Competition policy: consequences of restrictive trade practices and price-fixing provisions for medical practitioners in Australia and New Zealand Journal of Law and Medicine.. 13: 439-464. PMID 16756214  0.092
1992 Janes H. Internal variation in the uptake of whooping cough immunisation within a health authority Public Health. 106: 367-374. PMID 1410221 DOI: 10.1016/S0033-3506(05)80185-4  0.091
1988 Giniger MS, McAvoy RJ, Giacomelli GA, Janes HW. COMPUTER SIMULATION OF A SINGLE TRUSS TOMATO CROPPING SYSTEM Transactions of the American Society of Agricultural Engineers. 31: 1176-1179. DOI: 10.13031/2013.30840  0.09
2013 Abu-Raddad LJ, Barnabas RV, Janes H, Weiss HA, Kublin JG, Longini IM, Wasserheit JN. Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load? Aids (London, England). 27: 2494-6. PMID 24029738 DOI: 10.1097/01.Aids.0000432463.23508.A2  0.09
1998 Sauser BJ, Giacomelli GA, Janes HW. Modeling the effects of air temperature perturbations for control of tomato plant development Acta Horticulturae. 456: 87-92.  0.088
2000 Arias R, Lee TC, Logendra L, Janes H. Correlation of lycopene measured by HPLC with the L*, a*, b* color readings of a hydroponic tomato and the relationship of maturity with color and lycopene content Journal of Agricultural and Food Chemistry. 48: 1697-1702. PMID 10820081 DOI: 10.1021/Jf990974E  0.087
1997 Wulster G, Janes HW. Effects of supplemental light quality, quantity, and differential temperature on growth and development of easter lily (lilium longiflorum) Acta Horticulturae. 418: 153-157.  0.085
1978 Janes HB, Thompson MC. Fading at 9.6 GHz on an Experimentally Simulated Aircraft-to-Ground Path Ieee Transactions On Antennas and Propagation. 26: 715-719. DOI: 10.1109/TAP.1978.1141918  0.084
1985 Janes HW, Eaton RM, Wilson J. UHF Syledis for coastal survey positioning ( Canada) International Hydrographic Review. 62: 59-73.  0.083
1990 Moran JS, Janes HR, Peterman TA, Stone KM. Increase in condom sales following AIDS education and publicity, United States. American Journal of Public Health. 80: 607-8. PMID 2327542  0.082
2021 Matrajt L, Eaton J, Leung T, Dimitrov D, Schiffer JT, Swan DA, Janes H. Optimizing vaccine allocation for COVID-19 vaccines: critical role of single-dose vaccination. Medrxiv : the Preprint Server For Health Sciences. PMID 33469590 DOI: 10.1101/2020.12.31.20249099  0.082
1973 Janes HB, Thompson MC. Comparison of Observed and Predicted Phase-Front Distortion in Line-of-Sight Microwave Signals Ieee Transactions On Antennas and Propagation. 263-266. DOI: 10.1109/TAP.1973.1140457  0.081
2021 Matrajt L, Eaton J, Leung T, Dimitrov D, Schiffer JT, Swan DA, Janes H. Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination. Nature Communications. 12: 3449. PMID 34103510 DOI: 10.1038/s41467-021-23761-1  0.079
2011 Roberts JE, Miranda M, Boccia M, Janes H, Tonnsen BL, Hatton DD. Treatment effects of stimulant medication in young boys with fragile X syndrome. Journal of Neurodevelopmental Disorders. 3: 175-84. PMID 21671049 DOI: 10.1007/S11689-011-9085-4  0.079
2005 Linky EJ, Janes H, Cavazzoni J. Affordable technologies for utilization of methane in a landfill environment: An example of an integrated technology array and evolving institutional networks Natural Resources Forum. 29: 25-36.  0.075
2004 Logendra LS, Mun JG, Gianfagna TJ, Janes HW. Ethephon concentrates and advances harvest for limited cluster greenhouse tomato crops Hortscience. 39: 1650-1651.  0.071
1955 Norton KA, Rice PL, Janes HB, Barsis AP. The Rate of Fading in Propagation through a Turbulent Atmosphere Proceedings of the Ire. 43: 1341-1353. DOI: 10.1109/JRPROC.1955.277947  0.069
1955 Janes HB, Wells PI. Some Tropospheric Scatter Propagation Measurements Near the Radio Horizon Proceedings of the Ire. 43: 1336-1340. DOI: 10.1109/JRPROC.1955.277946  0.066
1973 Janes HB, Thompson MC, Smith D. Tropospheric Noise in Microwave Range-Difference Measurements Ieee Transactions On Antennas and Propagation. 256-260. DOI: 10.1109/TAP.1973.1140460  0.065
2013 Abu-Raddad LJ, Barnabas RV, Janes H, Weiss HA, Kublin JG, Longini IM, Wasserheit JN. Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load? Aids (London, England). 27: 981-9. PMID 23196933 DOI: 10.1097/QAD.0b013e32835cb927  0.065
2005 Janes H, Sheppard L, Lumley T. Do subject characteristics modify the effects of particulate air pollution on daily mortality among the elderly? Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 47: 543; author reply 54. PMID 15951711 DOI: 10.1097/01.Jom.0000163606.63666.9E  0.064
2002 Logendra LS, Gilrain MR, Gianfagna TJ, Janes HW. Swiss chard: a salad crop for the space program Life Support & Biosphere Science : International Journal of Earth Space. 8: 173-179. PMID 12481809  0.063
2000 Arias R, Lee TC, Specca D, Janes H. Quality comparison of hydroponic tomatoes (Lycopersicon esculentum) ripened on and off vine Journal of Food Science. 65: 545-548. PMID 11543432  0.061
1970 Thompson MC, Janes HB. Measurements of Phase-Front Distortion on an Elevated Line-of-Sight Path Ieee Transactions On Aerospace and Electronic Systems. 645-656. DOI: 10.1109/TAES.1970.310065  0.061
1988 McAvoy RJ, Janes HW. Alternative production strategies for greenhouse tomatoes using supplemental lighting Scientia Horticulturae. 35: 161-166. DOI: 10.1016/0304-4238(88)90109-4  0.061
2006 Fleisher DH, Logendra LS, Moraru C, Both AJ, Cavazzoni J, Gianfagna T, Lee TC, Janes HW. Effect of temperature perturbations on tomato (Lycopersicon esculentum Mill.) quality and production scheduling Journal of Horticultural Science and Biotechnology. 81: 125-131. DOI: 10.1080/14620316.2006.11512038  0.059
2000 Lefsrud MG, Giacomelli GA, Janes HW, Kliss MH. Development of the Micro Gravity Plant Growth Pocket 2000 Asae Annual Intenational Meeting, Technical Papers: Engineering Solutions For a New Century. 2: 4461-4473. DOI: 10.13031/2013.15635  0.057
2002 Chen BY, Janes HW, Chen S. Computer programs for PCR primer design and analysis Methods in Molecular Biology (Clifton, N.J.). 192: 19-29. PMID 12494633  0.055
1999 Kermani H, Janes HA. Adjustment across task in maternal scaffolding in low-income Latino immigrant families Hispanic Journal of Behavioral Sciences. 21: 134-153.  0.054
1981 Janes HW, Chin CK. The effect of age and growing conditions on cyanide resistance in cultured tomato roots Plant Science Letters. 23: 307-313. DOI: 10.1016/0304-4211(81)90041-9  0.054
1962 Norton KA, Barrows EC, Thompson MC, Janes HB. Variance of Radio Frequency Caused by Atmospheric Turbulence in Line-of-Sight Transmissions Ire Transactions On Instrumentation. 153-155. DOI: 10.1109/IRE-I.1962.5006620  0.053
1998 Gianfagna TJ, Logendra L, Durner EF, Janes HW. Improving tomato harvest index by controlling crop height and side shoot production Life Support & Biosphere Science : International Journal of Earth Space. 5: 255-261. PMID 11541684  0.05
1991 Janes HW. An error budget for GPS relative positioning Surveying & Land Information Systems. 51: 133-137.  0.05
1970 Janes HB, Thompson MC, Smith D, Kirkpatrick AW. Comparison of Simultaneous Line-of-Sight Signals at 9.6 and 34.5 GHz Ieee Transactions On Antennas and Propagation. 447-451. DOI: 10.1109/TAP.1970.1139715  0.047
1990 Logendra S, Putman JD, Janes HW. The influence of light period on carbon partitioning, translocation and growth in tomato Scientia Horticulturae. 42: 75-83. DOI: 10.1016/0304-4238(90)90149-9  0.046
1979 Veldre IA, Janes HJ. Toxicological studies of shale oils, some of their components, and commercial products Environmental Health Perspectives. 141-146. PMID 571802  0.044
1997 Globig S, Rosen I, Janes HW. Continuous light effects on photosynthesis and carbon metabolism in tomato Acta Horticulturae. 418: 141-151.  0.044
2005 Janes H, Cavazzorai J, Alagappan G, Specca D, Willis J. Landfill gas to energy: A demonstration controlled environment agriculture system Hortscience. 40: 279-282.  0.043
1992 Logendra S, Janes HW. Light duration effects on carbon partitioning and translocation in tomato Scientia Horticulturae. 52: 19-25. DOI: 10.1016/0304-4238(92)90004-V  0.043
2013 Abu-Raddad LJ, Barnabas RV, Janes H, Weiss HA, Kublin JG, Longini IM, Wasserheit JN. Understanding HIV epidemics: aggregate viral load metrics and 'smoking guns'. Aids (London, England). 27: 2826-7. PMID 24384634 DOI: 10.1097/Qad.0000000000000002  0.042
2000 Lefsrud MG, Giacomelli GA, Janes HW, Dreschel TW. Crop Production on the Porous Tube 2000 Asae Annual Intenational Meeting, Technical Papers: Engineering Solutions For a New Century. 2: 4415-4429.  0.042
2004 Logendra LS, Gianfagna TJ, Janes HW. Preventing side shoot development with C8/C10 fatty acids increases yield and reduces pruning time in greenhouse tomato Hortscience. 39: 1652-1654.  0.042
1971 Thompson MC, Janes HB. Effects of Sea Reflections on Phase of Arrival of Line-of-Sight Signals Ieee Transactions On Antennas and Propagation. 19: 105-108. DOI: 10.1109/TAP.1971.1139868  0.041
1998 Chen BY, Janes HW. Multiple forms of ADP-glucose pyrophosphorylase from tomato leaf Physiologia Plantarum. 103: 491-496. DOI: 10.1034/j.1399-3054.1998.1030407.x  0.041
1975 Thompson MC, Wood LE, Janes HB, Smith D. Phase and Amplitude Scintillations in the 10 to 40 GHz Band Ieee Transactions On Antennas and Propagation. 23: 792-797. DOI: 10.1109/Tap.1975.1141196  0.04
2005 Luo YY, Gianfagna TJ, Janes HW, Huang B, Wang Z, Xing J. Expression of the ipt gene with the AGPase S1 promoter in tomato results in unbranched roots and delayed leaf senescence Plant Growth Regulation. 47: 47-57. DOI: 10.1007/S10725-005-8647-4  0.04
2002 Li X, Xing J, Gianfagna TJ, Janes HW. Sucrose regulation of ADP-glucose pyrophosphorylase subunit genes transcript levels in leaves and fruits. Plant Science : An International Journal of Experimental Plant Biology. 162: 239-44. PMID 11989489 DOI: 10.1016/S0168-9452(01)00565-9  0.037
2001 Logendra LS, Gianfagna TJ, Specca DR, Janes HW. Greenhouse tomato limited cluster production systems: Crop management practices affect yield Hortscience. 36: 893-896. PMID 11858257  0.035
1975 Thompson MC, Janes HB, Wood LE, Smith D. Phase and Amplitude Scintillations at 9.6 GHz on an Elevated Path Ieee Transactions On Antennas and Propagation. 23: 850-854. DOI: 10.1109/Tap.1975.1141188  0.034
1981 Mears DR, Roberts WJ, Simpkins JC, Janes HW. LOW TEMPERATURE SOLAR HEATING OF GREENHOUSES Asae Publication. 2: 536-539.  0.032
1981 Janes HW, Rychter A, Frenkél C. Development of cyanide-resistant respiration in mitochondria from potato tubers treated with ethanol, acetaldehyde, and acetic acid Planta. 151: 201-205. DOI: 10.1007/Bf00395170  0.032
2001 Janes H, Kermani H. Caregivers' story reading to young children in family literacy programs: Pleasure or punishment? Journal of Adolescent and Adult Literacy. 44: 458-466.  0.032
1987 Hurewitz J, Janes HW. The relationship between the activity and the activation state of RuBP carboxylase and carbon exchange rate as affected by sink and developmental changes Photosynthesis Research. 12: 105-117. DOI: 10.1007/BF00047941  0.031
2005 Xing J, Li X, Luo Y, Gianfagna TJ, Janes HW. Isolation and expression analysis of two tomato ADP-glucose pyrophosphorylase S (large) subunit gene promoters Plant Science. 169: 882-893. DOI: 10.1016/J.Plantsci.2005.06.004  0.031
2013 Janes H. Letter to the editor. Biostatistics (Oxford, England). 14: 807-8. PMID 23624212 DOI: 10.1093/biostatistics/kxt013  0.03
2001 Logendra LS, Gianfagna TJ, Janes HW. Using mini-rockwool blocks as growing media for limited-cluster tomato production Horttechnology. 11: 175-179. PMID 12192681  0.03
2023 Stephenson KE, Marcelin JR, Pettifor AE, Janes H, Brown E, Neradilek M, Yen C, Andriesen J, Grunenberg N, Espy N, Trahey M, Fischer RSB, DeSouza CA, Shisler JL, Connick E, et al. Efficacy of Messenger RNA-1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021. Open Forum Infectious Diseases. 10: ofad511. PMID 38023544 DOI: 10.1093/ofid/ofad511  0.028
1998 Chen BY, Wang Y, Janes HW. ADP-glucose pyrophosphorylase is localized to both the cytoplasm and plastids in developing pericarp of tomato fruit Plant Physiology. 116: 101-106. PMID 9449839  0.028
1997 Chen BY, Janes HW. Multiple forms of ADP-glucose pyrophosphorylase from tomato fruit Plant Physiology. 113: 235-241. PMID 9008396  0.028
1998 Chen BY, Janes HW, Gianfagna T. PCR cloning and characterization of multiple ADP-glucose pyrophosphorylase cDNAs from tomato Plant Science. 136: 59-67. PMID 11543346 DOI: 10.1016/S0168-9452(98)00095-8  0.026
1991 Guan HP, Janes HW. Light regulation of sink metabolism in tomato fruit: II. Carbohydrate metabolizing enzymes Plant Physiology. 96: 922-927.  0.025
1966 Thompson MC, Janes HB. Antenna Aperture Size Effect on Tropospheric Phase Noise Ieee Transactions On Antennas and Propagation. 14: 800-802. DOI: 10.1109/TAP.1966.1138800  0.025
1911 Janes HL. Commercial relations of chile The Annals of the American Academy of Political and Social Science. 37: 153-159. DOI: 10.1177/000271621103700313  0.024
2017 Kerr KF, Brown M, Janes H. Reply to A.J. Vickers et al. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 35: 473-475. PMID 28129522 DOI: 10.1200/JCO.2016.70.4288  0.022
1956 SEARS HJ, JANES H, SALOUM R, BROWNLEE I, LAMOREAUX LF. Persistence of individual strains of Escherichia coli in man and dog under varying conditions Journal of Bacteriology. 71: 370-372. PMID 13306711  0.021
1952 JANES HH, TADDEO MC. Leiomyosarcoma of jejunum, 17-year history, simulating chronic duodenal ulcer Annals of Surgery. 136: 887-892. PMID 12986669  0.02
1991 Guan HP, Janes HW. Light regulation of sink metabolism in tomato fruit I. Growth and sugar accumulation Plant Physiology. 96: 916-921.  0.019
2003 Lefsrud MG, Giacomelli GA, Janes HW, Kliss MH. Development of the microgravity plant growth pocket Transactions of the American Society of Agricultural Engineers. 46: 1647-1651.  0.014
1980 Baker J, Grace J, Janes H, Lindley B. A specialized service for handicapped children Health Visitor. 53: 164-165. PMID 6445885  0.01
Hide low-probability matches.